​

10x Genomics Ownership | Who Owns 10x Genomics?

OverviewForecastRevenueFinancialsChartTranscripts

10x Genomics Ownership Summary

10x Genomics is owned by 98.85% institutional investors, 1.87% insiders. Ark investment management is the largest institutional shareholder, holding 11.23% of TXG shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 7.41% of its assets in 10x Genomics shares.

TXG Ownership Benchmark

TypeName% Inst% Insiders% Retail
Stock10x Genomics98.85%1.87%-0.72%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryHealthcare Information Services Stocks 54.77%12.92%32.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ark investment management13.89M11.23%$160.87M
Fmr13.45M11.14%$193.21M
Vanguard group10.93M9.06%$157.01M
Blackrock funding, inc. /de9.43M7.62%$109.25M
Blackrock6.39M5.35%$124.34M
Nikko asset management americas6.01M4.86%$69.53M
Morgan stanley5.77M4.84%$112.30M
Sumitomo mitsui trust5.38M4.35%$62.91M
Venrock management vi2.11M1.76%$40.98M
Ubs asset management americas2.12M1.75%$30.39M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Venrock management vi2.11M100.00%$40.98M
Blue water life science advisors, lp1.10M10.09%$12.75M
Lancaster investment management621.78K3.12%$7.27M
Ark investment management13.89M1.18%$160.87M
Sands capital ventures481.77K1.10%$5.58M
Nikko asset management americas6.01M0.69%$69.53M
Friedenthal financial79.03K0.48%$923.90K
Numerai gp244.86K0.41%$2.84M
Bayforest capital71.83K0.40%$839.66K
Pdt partners499.89K0.33%$5.79M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de9.43M0.00%2.77M
D. e. shaw1.22M0.01%1.22M
Blue water life science advisors, lp1.10M10.09%1.10M
Ark investment management13.89M1.18%1.05M
Two sigma investments, lp1.32M0.04%982.20K

Top Sellers

HolderShares% AssetsChange
Generation investment management llp---2.88M
Brown capital management---1.84M
Assenagon asset management14.58K0.00%-1.70M
Deerfield management company, l.p. (series c)11.30K0.00%-1.49M
Ra capital management475.34K0.09%-1.47M

New Positions

HolderShares% AssetsChangeValue
D. e. shaw1.22M0.01%1.22M$17.50M
Blue water life science advisors, lp1.10M10.09%1.10M$12.75M
T. rowe price investment management977.68K0.01%977.68K$11.32M
Bnp paribas arbitrage, snc632.53K0.01%632.53K$9.08M
Lancaster investment management621.78K3.12%621.78K$7.27M

Sold Out

HolderChange
Concourse financial group securities-3.00
Mather group, llc.-4.00
Manchester capital management-4.00
Northwest investment counselors-6.00
Princeton global asset management-9.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252997.94%122,334,8068.44%981.17%18519.35%73-1.35%
Mar 31, 2025277-0.72%113,747,6058.46%921.22%1553.33%74-20.43%
Dec 31, 2024264-1.86%102,915,574-1.38%851.14%143-10.06%8519.72%
Sep 30, 20242671.14%104,336,340-0.97%861.12%1578.28%71-7.79%
Jun 30, 2024262-10.58%105,357,3692.80%881.20%145-14.71%75-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Disruptive Innovation Full Composite9.22M7.41%555.60K
ARK Innovation ETF7.15M5.74%-109.56K
Vanguard US Total Market Shares ETF3.24M2.65%268.60K
Vanguard Total Stock Mkt Idx Inv3.26M2.62%-72.23K
ARK Genomic Revolution3.24M2.60%274.39K
ARK Genomic Revolution ETF3.22M2.59%-11.50K
Nikko AM ARK Disruptive Innovation A USD3.14M2.55%126.16K
Amova ARK Disruptive Innovation A USD2.97M2.39%-167.66K
Vanguard Small Cap Index2.56M2.06%-13.44K
iShares Russell 2000 ETF2.55M2.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 22, 2025Saxonov Serge Chief Executive OfficerSell$128.88K
Aug 22, 2025Taich Adam Chief Financial OfficerSell$307.66K
Aug 22, 2025Hindson Benjamin J. See RemarksSell$103.21K
May 22, 2025Saxonov Serge Chief Executive OfficerSell$77.54K
May 22, 2025Hindson Benjamin J. See RemarksSell$62.12K

Insider Transactions Trends

DateBuySell
2025 Q2-3
2025 Q113
2024 Q4-2
2024 Q3-3
2024 Q2-3

TXG Ownership FAQ

Who Owns 10x Genomics?

10x Genomics shareholders are primarily institutional investors at 98.85%, followed by 1.87% insiders and -0.72% retail investors. The average institutional ownership in 10x Genomics's industry, Healthcare Information Services Stocks , is 54.77%, which 10x Genomics exceeds.

Who owns the most shares of 10x Genomics?

10x Genomics’s largest shareholders are Ark investment management (13.89M shares, 11.23%), Fmr (13.45M shares, 11.14%), and Vanguard group (10.93M shares, 9.06%). Together, they hold 31.43% of 10x Genomics’s total shares outstanding.

Does Blackrock own 10x Genomics?

Yes, BlackRock owns 5.35% of 10x Genomics, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.34M$. In the last quarter, BlackRock increased its holdings by 385.01K shares, a 6.41% change.

Who is 10x Genomics’s biggest shareholder by percentage of total assets invested?

Venrock management vi is 10x Genomics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 2.11M 10x Genomics shares, valued at 40.98M$.

Who is the top mutual fund holder of 10x Genomics shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of 10x Genomics shares, with 7.41% of its total shares outstanding invested in 9.22M 10x Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools